In a recent transaction on March 19, Stuart M. Grant, a significant shareholder of Eyenovia, Inc. (NASDAQ:EYEN), acquired 50,000 shares of the company's common stock. The purchase, executed at an average price of $1.23 per share, resulted in a total investment of $61,500.
This acquisition has increased Grant's direct ownership in the pharmaceutical preparations company to 5,330,715 shares. The transaction was made public through a Form 4 filing with the Securities and Exchange Commission.
Eyenovia, Inc., based in New York, is known for its specialization in the development of ophthalmic pharmaceuticals. The company's stock is traded on the NASDAQ exchange under the ticker symbol EYEN.
Investors often monitor insider transactions as they can provide insights into the company's performance and potential future direction. The recent purchase by a major shareholder may be of particular interest to the market, reflecting a direct investment in the company's stock at a specific price point.
For further details and updates on Eyenovia, Inc. and its stock performance, investors are encouraged to review the company's filings and press releases.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.